As of January 22, 2025, Plant Advanced Technologies PAT SA (ALPAT.PA) has a market cap of $13.727 million USD. According to our data, Plant Advanced Technologies PAT SA is ranked No.8746 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $13.73 M |
0.00%
|
Dec 31, 2024 | $13.73 M |
40.83%
|
Dec 29, 2023 | $9.75 M |
-36.47%
|
Dec 30, 2022 | $15.34 M |
-28.49%
|
Dec 31, 2021 | $21.46 M |
-10.58%
|
Dec 31, 2020 | $23.99 M |
5.05%
|
Dec 31, 2019 | $22.84 M |
22.98%
|
Dec 31, 2018 | $18.57 M |
-34.50%
|
Dec 29, 2017 | $28.35 M |
31.37%
|
Dec 30, 2016 | $21.58 M |
-27.82%
|
Dec 30, 2015 | $29.90 M |
-20.71%
|
Dec 31, 2014 | $37.71 M |
67.64%
|
Dec 31, 2013 | $22.49 M |
8.33%
|
Dec 28, 2012 | $20.76 M |
20.48%
|
Dec 30, 2011 | $17.23 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$364.81 B |
95.450 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Roche
ROG.SW
|
$243.84 B |
38.062 B
|
Switzerland
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CSL
CSL.AX
|
$82.07 B |
-0.055 B
|
Australia
|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$68.91 B |
-0.695 B
|
Japan
|
Market Cap | = | ALPAT.PA Stock Price | * | ALPAT.PA Shares Outstanding |
= | $12.29 | * | 1.11 M | |
= | $13.73 M |